Cardiology

Latest News

Improving CVD Outcomes Through Better Recommendations, Patient Monitoring
Improving CVD Outcomes Through Better Recommendations, Patient Monitoring

March 27th 2024

Researchers detailed the FDA’s recommendations on low-dose aspirin and pharmacists’ role in cardiovascular practice transformation programs.

FDA Approves Sotatercept-csrk for Pulmonary Arterial Hypertension
FDA Approves Sotatercept-csrk for Pulmonary Arterial Hypertension

March 27th 2024

FDA approval stamp | Image credit: Olivier Le Moal - stock.adobe.com
FDA Approves Label Expansions, New Indication for Bempedoic Acid Tablets for CV Prevention

March 22nd 2024

FDA Approves Aprocitentan For Treatment of Uncontrolled High Blood Pressure
FDA Approves Aprocitentan For Treatment of Uncontrolled High Blood Pressure

March 20th 2024

Focus On Obesity Management Before Addressing Comorbidities
Focus On Obesity Management Before Addressing Comorbidities

March 20th 2024

Video Interviews
Latest CME Events & Activities

Risks and Liabilities in Pharmacy Practice

1.0 Credit / Law

View More

The Management of HFrEF With New and Emerging Mechanisms of Action: Updates for Pharmacists

1.5 Credits / Cardiology

View More

Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns

1.0 Credit / Law

View More

Recent Advances in Omega-3 Fatty Acids to Reduce Risk of ASCVD in Patients With Elevated Triglyceride Levels

0.75 Credit / Cardiology

View More

Introduction to Anticoagulation and the Appropriate Patient

1.0 Credit / Cardiology

View More

Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications

1.5 Credits / Law, Oncology

View More

The Treatment Landscape and a Review of Approved DOAC Agents

1.0 Credit / Cardiology

View More

Maximizing Patient Outcomes Through Pharmacist-Led Homozygous Familial Hypercholesterolemia Management

1.0 Credit / Cardiology

View More

Setting the Stage: An Introduction to Worsening Heart Failure Events in Patients With Heart Failure With Reduced Ejection Fraction

1.0 Credit / Cardiology

View More

Navigating the Therapeutic Landscape of Homozygous Familial Hypercholesterolemia

1.0 Credit / Cardiology

View More

Understanding the Challenges of Homozygous Familial Hypercholesterolemia

1.0 Credit / Cardiology

View More

The Role of the Pharmacist in Optimizing DOAC Utilization Across Practice Settings

1.0 Credit / Cardiology

View More

Soluble Guanylate Cyclase Stimulators in the Management of Worsening Heart Failure With Reduced Ejection Fraction

1.0 Credit / Cardiology

View More

Individualizing Care for Patients With Heart Failure: The Role of the Pharmacist in Optimizing Education and Improving Adherence

1.0 Credit / Cardiology

View More

Advancing Chronic Worsening Heart Failure Treatment: The Critical Role of Pharmacists in Therapy Integration

1.0 Credit / Cardiology

View More

Iron Deficiency and Anemia in Heart Failure: Clinical Applications for the Use of Intravenous Iron

1.5 Credits / Cardiology

View More

Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure with Preserved Ejection Fraction

1.0 Credits / Cardiology

View More

Child Abuse: Responsibilities and Protection of the Reporter

1.0 Credit / Law

View More

More News

© 2024 MJH Life Sciences

All rights reserved.